What is JANX's dilution risk score?

JANX has a latest available DilutionScore record of 27/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for JANX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for JANX?

DilutionWatch tracks 25 SEC filing types for JANX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect JANX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For JANX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for JANX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for JANX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

JANX Dilution Risk Score: 27/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

0

📊 Float Risk

30

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for JANX.

🔔 Track JANX — Get forecast alerts →

Market Data

Market Cap$889.76M

Shares Outstanding61.14M

Float39.19M

Cash$970.91M

Debt$21.57M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 9.0% shares (2026Q1 vs prior)

193 institutional holders · 70.52M shares

#1 RA CAPITAL MANAGEMENT, L.P. 11.19M shares

#2 JANUS HENDERSON GROUP PLC 8.39M shares

#3 BlackRock, Inc. 5.43M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.92M

Days to Cover7.7

% of Float15.1%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

4 INSIDER TRANSACTION 2026-02-04

3 FORM3 2026-02-04

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual JANX Dilution Snapshot

Janux Therapeutics, Inc. (JANX) has a DilutionScore of 27/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for JANX: 4 on 2026-02-04; 3 on 2026-02-04.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.